Delaware Pharmacy CE Requirement 30-Hour Package
Included Courses
Courses included in this package. Click on a course to learn more.
- Clinical Management of Substance Use Disorders 5
Course release date: 7/10/2023
About the Course
Substance use and abuse cost society more than $740 billion annually in workplace productivity, healthcare, and crime-related expenses (NIDA, 2020). Substance use disorders are complex phenomena affecting individuals' and families’ lives. This course reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. The course also examines federal and state-controlled substance regulations and the prescribing practices for controlled substances. The focus is on clinical and safety considerations by nurse practitioners when prescribing non-cancer-related opioid medications for acute/chronic pain. - Pain Management Awareness for Pharmacists, Second Edition 2Course release date: 4/20/22About the Course:Pain is not always curable, and there are a number of approaches to its treatment. The appropriate treatment plan can vary significantly, depending on the cause of pain, patient-specific factors, and personal preference. A comprehensive pain treatment plan is often a multimodal approach, requiring the use of both pharmacological and non-pharmacological treatment options. A thorough understanding of the available therapies is necessary to provide optimal care to a patient in pain. This course serves as an overview of pain, its evaluation, and treatment (US National Library of Medicine, 2021).
- Patient Safety and Medication Errors for Pharmacy Professionals 2
Course Release: 4/1/2024
About the course
This educational program is designed to accomplish at least two important goals: first to provide examples of critical potential medication errors, and secondly to offer mechanisms that pharmacy professionals can take to intervene in these mishaps and enhance patient care. In addition to offering these critical examples and potential solutions, two case studies are included to help put some of the ideas into realistic scenarios similar to those that may be encountered in contemporary pharmacy practice. Evidence-based practice information from current peer-reviewed literature is also included for context and ideas for pharmacists to consider in efforts to improve their practice appear throughout the program. Lastly, a post-test is included at the end of the program to test your understanding of the material.
- Pharmacotherapy to Assist with Smoking Cessation 3Release Date: 1/26/2021
About the Course:
After completing this course, pharmacists will be able to help select first-line pharmacotherapy to assist smokers in quitting, educate smokers on potential adverse effects of these pharmacotherapies, and provide counseling that includes how and when to properly take the medication - Pharmacy Law: Federal Regulations & HIPAA 4
Course release date: 8/9/2024
About the Course
Pharmacy is, by far, the most regulated profession in health care. Pharmacists have a professional obligation to stay current in their knowledge of laws and regulations and their implications to practice and patient care. Federal drug legislation has distinguished between prescription and over-the-counter medications and established that drugs must be both safe and effective, must be properly labeled, and must be manufactured and stored under sanitary conditions. In addition, the Controlled Substances Act (CSA) has expanded regulatory oversight and scheduling of medications to minimize diversion, misuse, and abuse. Federal legislation has been enacted to combat methamphetamine abuse, deter tampering with medications, ensure patient privacy, and mandate patient counseling. It is important to understand the scope of laws and regulations so that we can practice in accordance. Federal and state laws are meant to operate concurrently. If one law is more strict, that is the law we must follow as pharmacists.
- The Complications of Chronic Kidney Disease, Second Edition 2
Release Date: 7/10/2023
About the Course:
This course serves as a review of chronic kidney disease (CKD) and the medications used to prevent adverse effects of CKD and slow disease progression. - The Essentials of Infection Prevention 4
Course release date: 7/10/2023
About the Course
The COVID-19 pandemic made all healthcare workers acutely aware of infection prevention and control measures. The pandemic has highlighted the need for ongoing education to maintain a knowledge and skill level appropriate for implementing strategies to prevent healthcare-associated infections and to prepare for the next pandemic. Understanding where reservoirs are harboring pathogens and strategies to prevent transmission in healthcare settings is critical. This course will examine best practices for infection prevention, such as hand hygiene, personal protective equipment, transmission-based precautions, cleaning and disinfection, and injection safety
- The Pharmacist's Role in the Opioid Crisis, 2nd Edition 6
Course Release: 1/9/2024
About the course
This course will provide pharmacists practicing in healthcare systems and community pharmacy settings an overview of contemporary considerations for ways that the opioid crisis intersects with pharmacy practice. This course will provide pharmacists with a history of the current state of the opioid crisis and how pharmacy practice has expanded to meet patient and community needs as well as ethical dimensions of the opioid crisis and the role of social determinants of health in opioid-related disparities. This course will provide pharmacists with an understanding of the disease state of opioid use disorder and how opioids affect the brain, how the pharmacist can be supportive of patients with opioid use disorder to reduce stigma and facilitate treatment-seeking, and the benefits of medications for opioid use disorder; participants will review the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022 Clinical Practice Guideline).
- The Pharmacologic Management of Anxiety in Adults 2Release Date: 7/10/2023About the CourseAnxiety disorders are the most commonly diagnosed psychiatric disorders, with an estimated 264 million persons globally suffering from an anxiety disorder. It’s estimated that 19.1% of adults in the United States (U.S.) are affected by at least one anxiety disorder; this number increases to 31.9% in U.S. adolescents. Common anxiety disorders include generalized anxiety disorder (GAD), panic disorder (PD), specific phobias, agoraphobia, social anxiety disorder (SAD), and separation anxiety disorder. This course reviews the diagnosis and pharmacological management of anxiety disorders, as well as medications which can cause or exacerbate anxiety symptoms.